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Multiple BRCA1-specific antibodies detect a protein
migrating at z220 kDa in various cell lines (Chen et al.,
1995; Scully et al., 1996). This polypeptide comigratesSummary
with and has a peptide map indistinguishable from that
of the 220 kDa clonal BRCA1 in vitro translation productBRCA1 immunostaining reveals discrete, nuclear foci
(Chapman and Verma, 1996; Scully and Livingston, un-during S phase of the cell cycle. Human Rad51, a ho-
published data). Several reports indicate that p220molog of bacterial RecA, behaves similarly. The two
BRCA1 is a nuclear protein in cultured cells and normalproteins were found to colocalize in vivo and to coim-
tissues (Chen et al., 1995; Chapman and Verma, 1996;munoprecipitate. BRCA1 residues 758±1064 alone
Chen et al., 1996; Scully et al., 1996).formed Rad51-containing complexes in vitro. Rad51
The developmental pattern of murine BRCA1 expres-is also specifically associated with developing synap-
sion (Lane et al., 1995; Marquis et al., 1995) and its celltonemal complexes in meiotic cells, and BRCA1 and
cycle±regulated expression (Gudas et al., 1995; GudasRad51 were both detected on asynapsed (axial) ele-
et al., 1996; Vaughn et al., 1996) suggest a relationshipments of human synaptonemal complexes. These find-
between BRCA1 function and cellular proliferation (e.g.,ings suggest a functional interaction between BRCA1
in the mammarygland in response toovarian hormones).and Rad51 in the meioticand mitotic cell cycles, which,
Loss of BRCA1 function is a lethal event during murinein turn, suggests a role for BRCA1 in the control of
embryogenesis (Gowen et al., 1996; Hakem et al., 1996;recombination and of genome integrity.
Liu et al., 1996). Some BRCA12/2 embryos revealed an
early (zE7.5) proliferation block with elevated levels ofIntroduction
p21 mRNA at E4 (Hakem et al., 1996).
There are also reports of growth- and transformation-
Between 5% and 10% of all breast cancers and 10%
suppressing behavior, as well as death of cells that
of ovarian cancers can be attributed to mutations of
acutely overproduce BRCA1 (Holt et al., 1996; Rao et
highly penetrant, autosomal dominant susceptibility
al., 1996; Shao et al., 1996; Wilson et al., 1996). However,
genes (Newman et al., 1988; Claus et al., 1991). One of
these studies do not reveal the mechanism underlying
these is BRCA1, which maps to 17q21 (Hall et al., 1990; these effects.
Narod et al., 1991; reviewed in Feunteun and Lenoir,
We have reported that BRCA1 immunostaining is
1996). BRCA1 mutations are responsible for almost all
characterized by a ªnuclear dotº pattern (Scully et al.,
families with inherited breast and ovarian cancer and
1996). As suggested by the work of Chen et al. (1996)
for approximately half of the families with breast cancer and as defined below, BRCA1 nuclear dots appear in S
only (Easton et al., 1993). The detection of LOH affecting phase of the cell cycle. Among nuclear proteins known
the wild-type BRCA1 allele in tumors from BRCA1 muta- to be characterized by dot-like staining is human Rad51
tion carriers implies that BRCA1 is a tumor suppressor (hRad51), a homolog of bacterial RecA. hRad51 nuclear
gene (Smith et al., 1992; Neuhausen and Marshall, 1994). dots also appear in S phase (Tashiro et al., 1996).
The BRCA1 cDNA encodes an 1863 residue polypep- hRad51 is a member of a protein family known to
tide of as yet unknown biochemical function (Miki et mediate DNA strand±exchange functions leading to nor-
al., 1994). The BRCA1 sequence includes an N-terminal mal recombination (Kowalczykowski, 1991; Radding,
RING domain (reviewed in Freemont, 1993; Saurin et al., 1991; Sung, 1994; Sung and Robberson, 1995; Baumann
1996), a negatively charged region in its C terminus, et al., 1996). Although yeast, mutated for RAD51, cannot
and C-terminal sequences partiallyhomologous to yeast perform normal meiotic recombination and double-
RAD9 and to a cloned p53 binding protein (Koonin et stranded break repair, they are viable (Shinohara et al.,
al., 1996). The negatively charged segment may contrib- 1992). In contrast, mice bearing homozygous, loss-of-
ute to transcription-inducing activity of a GAL4±BRCA1 function RAD51 mutations died early in embryogenesis.
Moreover, like BRCA12/2 embryos, cells of RAD512/2
embryos revealed a proliferation defect, suggesting an§These authors contributed equally to this work.
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additional role for Rad51 in cell growth control (Lim and
Hasty, 1996; Tsuzuki et al., 1996). Here, we report that
BRCA1 and hRad51 colocalize in S phase cells, interact
physically, and, in keeping with previous reports of the
behavior of hRad51 (Ashley et al., 1995; Plug et al., 1996),
share common space on the surfaces of zygotene and
pachytene meiotic chromosomes. These observations
identify a biochemical pathway involving BRCA1 and
suggest that BRCA1 participates in nuclear processes
that lead to normal chromosomal recombination and
genome integrity control.
Results
S Phase Nuclear Dot Pattern of BRCA1
The identification of discrete, nuclear dot±like structures
as loci of endogenous BRCA1 protein in multiple cell
lines and diploid human fibroblasts has been estab-
lished previously, using seven different BRCA1 mono-
clonal antibodies (MAb's) and an affinity-purified BRCA1
polyclonal Ab (Scully et al., 1996). BRCA1 nuclear dots
were observed in only a fraction of asynchronous cells.
The remaining cells revealed a weaker, more diffuse
nuclear signal (data not shown). This suggested that the
dot-like staining might be cell cycle±dependent. Serum
starvation and synchronous release were used to syn-
chronize populations of the breast cancer cell line,
MCF7, which were then subjected to BRCA1 immuno-
staining. In cultures enriched for S phase cells (t 5 24
Figure 1. BRCA1 Nuclear Dot Pattern Arises in S Phasehr population; see Figure 1), most cells scored positively
MCF7 cells were serum-starved and released, as described in Ex-for BRCA1 nuclear dots, while a G1-enriched population
perimental Procedures. The figure depicts immunostaining usingpresented weaker and largely diffuse nuclear staining
BRCA1 MAb MS13. Identical results were obtained using two other
(t 5 12 hr; see Figure 1 and see also Chen et al., 1996). BRCA1 MAb's (MS110 and AP16). (t 5 12), cells 12 hr after serum
Analysis of the same cultures with irrelevant MAb re- release (83% G1, 9% S); (t 5 24), cells 24 hr after serum release
vealed no nuclear staining (Scully et al., 1996; data not (30% G1, 62% S).
shown). These and other results not shown here indicate
that the BRCA1 nuclear dot pattern is S phase±specific. The specificity of theaffinity-purified Rad51 antiserum
was assessed. Immunoblotting of an MCF7 cell extract
with this antiserum revealed a single band, migrating atColocalization of the BRCA1 and Rad51
Immunostaining Patterns 38 kDa, the expected size of hRad51 (data not shown).
This band disappeared afterpreabsorbing theantiserumin S Phase Nuclei
Rad51, a mammalian RecA homolog, has been shown with clonal GST±hRad51 but not with 10-fold more un-
fused GST. The same was true for the nuclear immuno-previously to form S phase±specific nuclear foci (Tashiro
et al., 1996). Given the apparent similarity in the timing fluorescence signal generated with this Ab. No reaction
between this antiserum and authentic BRCA1 was de-of appearance of Rad51 and BRCA1 nuclear dots, we
asked whether Rad51 and BRCA1 staining colocalize in tected by immunoblotting (data not shown).
the same structures. Two-color confocal immunostain-
ing with a BRCA1 monoclonal antibody and an affinity- Biochemical Evidence of an In Vivo
BRCA1±Rad51 Interactionpurified, rabbit polyclonal antiserum raised against
clonal human Rad51 (Haaf et al., 1995; Plug et al., 1996) MCF7, 293T, and HeLa cell immunoprecipitates gener-
ated with the BRCA1 MAb, SG11, contained endoge-revealed significant, albeit not complete, colocalization
of the BRCA1 and the Rad51 nucleardot patterns (Figure nous, 38 kDa Rad51, as determined by immunoblotting
(Figure 3A and data not shown). The Rad51 and BRCA12). Figure 2 also illustrates cell-to-cell variability in colo-
calization between BRCA1 and Rad51 signals. In some signals detected in SG11 immunoprecipitates were sup-
pressed by preincubation of this BRCA1 antibody withcells, colocalization of dot signals was extensive (e.g.,
Figures 2D±2F). In others, the overlap was incomplete the immunizing BRCA1 peptide. Only a fraction of the
ambient Rad51 coimmunoprecipitated with BRCA1 by(e.g., Figures 2A±2C, top cell). This suggested that the
colocalization of BRCA1 and Rad51 is conditional or this method. Although S phase extracts contained more
BRCA1±Rad51 complexes than G1 extracts (data nottransient, even in S phase cells. Similar colocalization
results were obtained in WI38 and CV-1 cells. These shown), even in S phase±enriched fractions, there was
incomplete coprecipitation of hRad51 with BRCA1.observations raised the possibility that BRCA1 and
Rad51 physically interact. Whether this results from the presence of an excess of
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Figure 2. BRCA1 and Rad51 Colocalize in Discrete Nuclear Foci
MCF7 cells were double-stained with BRCA1 MAb MS13 (green) and anti-Rad51 (red). (A) and (D), BRCA1 stain; (B) and (E), Rad51 stain; and
(C) and (F), composite BRCA1 and Rad51 stains. Where green and red signals overlap, a yellow pattern is seen, indicating colocalization of
BRCA1 and Rad51.
(A±C) Staining of asynchronously growing MCF7 cells, depicting the location of BRCA1 and Rad51 in a BRCA1 dot-containing cell and in a
cell exhibiting a more diffuse BRCA1 signal.
(D±E) Staining of serum-starved MCF7 cells, illustrating the rare (5%) S phase cell with a BRCA1 nuclear dot pattern.
Rad51 over BRCA1 and/or only a fraction of Rad51 is proteinÐin parallel transfections of the same cell line,
neither protein was detected in anti-Rad51 immunopre-competent to bind, directly or indirectly, to BRCA1 is
not known. cipitates (Figure 3C). Thus, further evidence of specific
complex formation between Rad51 and BRCA1 was ob-In an effort to confirm the existence of a physical
interaction between BRCA1 and Rad51, we asked tained in transiently transfected cells containing defini-
tively tagged gene products.whether BRCA1 would complex with epitope-tagged,
ectopic Rad51. Figure 3B shows that, after transient
transfection of HA-tagged Rad51 into 293T cells, both BRCA1 Exon 11 Encodes Sequences That
Mediate Rad51 Bindingendogenous BRCA1 and HA-tagged Rad51 were de-
tected in an anti-BRCA1 immunoprecipitate. The co- Six overlapping BRCA1 fragments spanning the entire
BRCA1 open reading frame were synthesized as GSTprecipitating band, identified as HA-Rad51, comigrated
with bands precipitated from the same extract with ei- fusion proteins (Figures 4A and 4B). Approximately
equal amounts of each protein, bound to glutathione-ther HA or Rad51 antibody. No such band precipitated
from untransfected cells with anti-HA MAb (Figure 3B). sepharose beads, were incubated with an extract of
BJAB (Burkitt's lymphoma±derived) cells. Bead-boundIn addition, transiently overproduced HA±E2F4 was not
detected in BRCA1 immunoprecipitates, despite the fact proteins were recovered and separated electrophoreti-
cally. The separated proteins were immunoblotted forthat its concentration was similar to that of HA±Rad51
(data not shown). Hence, the BRCA1 MAb used here Rad51 (Figure 4C). GST±BRCA1 fragment #4, corre-
sponding to BRCA1 residues 758±1064, which are en-did not recognize the HA tag. Moreover, this BRCA1
MAb failed to recognize in vitro translated HA-tagged coded by a portion of exon 11, repeatedly bound a 38
kDa immunoreactive Rad51 comigrating band. IdenticalRad51 synthesized in a wheat germ extract (data not
shown). Hence, it did not appear to recognize Rad51 results were obtained using cell lines MCF7, 293T, and
U2OS.independently.
In a reciprocal experiment, anti-Rad51 immunoprecip- To distinguish between bona fide hRad51 and a comi-
grating 38 kDa band supplied by the bacterial extract,itation of a HA-BRCA1-transfected 293T cell extract co-
precipitated BRCA1 (Figure 3C). Despite the presence the same experiment was performed with an extract
of 35S-methionine-labeled MCF7 cells (Figure 4D). Afterof higher levels of two HA-tagged control nuclear pro-
teinsÐthe p300 nuclear coactivator and the p130 pocket incubation of the various bead-bound GST proteins with
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this extract and washing, we eluted the bead-bound
proteins. After dilution of the individual eluates to reduce
theambient SDS concentration, the eluted proteins were
reimmunoprecipitated with the Rad51 antiserum. A la-
beled 38 kDa band did reimmunoprecipitate from an
eluate of the same lot of GST±BRCA1 #4 fragment-
bound beads that yielded the Rad51 immunoreactive
band in the earlier experiment (Figure 4C). No such band
appeared in the eluates of GST beads alone. Hence, the
protein recovered by the BRCA1 #4 fragment is Rad51
and originated in the mammalian and not the bacterial
extract.
Taken together, the data indicate that BRCA1 exon
11 encodes a sequence(s) that can serve as a specific
binding site for Rad51. Whether the BRCA1 interaction
with Rad51 is direct or depends upon BRCA1 binding
to an intermediate protein(s) is not clear at present.
Presence of BRCA1 on Meiotic Chromosomes
The association of BRCA1 and Rad51 in mitotic cells
and the known presence of Rad51 on synaptonemal
complexes of various organisms (Bishop, 1994; Ashley
et al., 1995; Terasawa et al., 1995; Plug et al., 1996)
suggested that the two proteins might also colocalize
during meiotic prophase. BRCA1 mRNA is highly ex-
pressed in spermatocytes during meiotic prophase
(Zabludoff et al., 1996).
The pairing of homologous chromosomes during mei-
osis is accompanied by the appearance of unique,
meiosis-specific DNA- and protein-bearing structures,
termed synaptonemal complexes. Following DNA repli-
cation in premeiotic S phase, meiotic chromosomes be-
gin to condense and a protein-containing core, or axial
element, forms between sister chromatids. As homolo-
gous chromosomes synapse in zygonema to form a
bivalent, the axial elements align and are joined by trans-
verse filaments. Finally, a discrete central element forms
between the two axial elements, completing the struc-Figure 3. Coimmunoprecipitation of BRCA1 and Rad51
ture of the synaptonemal complex. In the current study,(A) Association in untransfected cells. MCF7 cultures were enriched
we used an antibody to SCP3, a component of the axial/for S phase (see Experimental Procedures). Extracts (5 3 106 cells
per lane) were immunoprecipitated with the antibodies shown. Im- synaptic elements of this structure (Lammers et al.,
munoprecipitated proteins were separated by SDS±PAGE and im- 1994), to visualize the progression of meiotic prophase.
munoblotted with MAb MS110 (anti-BRCA1, upper panel; arrow sig- In nuclei of zygotene spermatocytes obtained from
nals the migration position of p220 BRCA1 [Scully et al., 1996]) and fresh, human testis, BRCA1 staining (in red) was ob-
with the Rad51 antiserum (arrow signals the presence of the 38
served with three different MAb's (MS13, MS110, andkDa protein). Control antibodies included the rabbit anti-mouse IgG
SG11 [Scully et al., 1996]). Chromosomal axes doublysecondary immunoprecipitation antibody (ªanti-mIgº) and MAb
stained with MAb MS110 (red) and Ab to SCP3 (white)SG11 that had been preincubated with a 10-fold molar excess of
the peptide against which it was raised. are shown in Figure 5. BRCA1 staining was detected in
(B) Coimmunoprecipitation of ectopic, HA-tagged Rad51 with an uneven pattern. On those structures where the spe-
BRCA1. 293T cells were transfected with an HA-Rad51 expression cific details of chromosomal anatomy were most clearly
plasmid. Extracts of the transfected cultures (z107 cells per lane) discernible, a significant fraction of the staining was
were subjected to immunoprecipitation 48 hr later. After SDS±PAGE,
noted along unsynapsed axial elements (small arrows,immunoblotting for p220 BRCA1 (using MAb MS110, upper panel)
Figure 5A), as well as at axes that were in the processand for the HA tag (using MAb 12CA5, lower panel) was performed.
of synapsing (larger arrows, Figure 5A). BRCA1 stainingImmunoblots of whole cell extracts clearly showed an HA-Rad51-
specific doublet migrating at 40±42 kDa (data not shown). The ab- was also detected on unsynapsed centromeric hetero-
sence of this doublet from an extract of untransfected cells indicated chromatin (arrowheads, Figure 5B), on remaining univa-
that the 40±42 kDa 12CA51 species depicted in the lower panel are lents (e.g., small arrow, Figure 5B), and at pairing forks
HA±Rad51 products. (e.g., larger arrow, Figure 5B). Figure 5D highlights the
(C) Coimmunoprecipitation of ectopic HA-BRCA1 with Rad51. 293T
cells were transfected, in parallel, with expression plasmids encod-
ing HA±BRCA1, HA±p130, or HA±p300, as shown. Transfected cell
extracts (z107 cells per lane) were immunoprecipitated. After SDS± p300 (300 kDa) are not reflected in the relative migration rates of
PAGE, anti-HA immunoblotting (using MAb 12CA5) was performed. these proteins, which, even in the untagged state, migrate close to
one another.Note that the nominal molecular weights of BRCA1 (220 kDa) and
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Many fewer chromosomes revealed detectable
BRCA1 staining in pachynema (Figure 5C). By contrast,
BRCA1 staining persisted on the asynapsed X-axis dur-
ing this period (Figure 5C). Indeed, as pachynema pro-
gressed, the BRCA1 signal seemed to be present in a
less interrupted manner on late-synapsing autosomal
axes (arrows, Figure 5C) and on the X chromosome (see
Figure 6), which has no homolog in males. These data
imply that the appearance of BRCA1 staining is a syn-
chronous event during meiotic prophase.
The BRCA1 MAb MS13 was raised against a defined
segment of the N-terminal region of the cloned protein
(residues 1±304, Scully et al., 1996). As another test of
specificity, we preincubated MAb MS13, in parallel, with
each of two purified BRCA1 fragments. One was the
initial MS13 immunogen. The other contained residues
1313±1863. These preincubated preparations were
used, in parallel, to stain pachytene spermatocytes.
Both Rad51 Ab and a second BRCA1 MAb, MS110,
costained the unsynapsed axis of the X chromosome
(data not shown). MAb MS13, preincubated with the
C-terminal BRCA1 fragment, noted above, also stained
the unsynapsed axis of the X chromosome (Figure 6B),
which was simultaneously costained with SCP3 Ab (Fig-
ure 6A). In contrast, MAb MS13, preincubated with the
relevant, immunizing N-terminal polypeptide, yielded no
signal despite the presence of the X in that spread (Fig-
Figure 4. In Vitro Binding of a Segment of BRCA1 to Rad51 ures 6C [SCP3 staining] and 6D).
Six GST±BRCA1 fusion proteins were generated in E. coli. (A) The The same experiment was performed with MAb
schematic diagram of these fusion proteins is not drawn to scale. MS110 (which, like MS13, was raised against BRCA1
BRCA1 exon 11 products are indicated by dense stippling. The residues 1±304) with identical results (data not shown).
amino-terminal BRCA1 RING domain is shown by light stippling.
MAb SG11, a third BRCA1 monoclonal Ab, led to a stain-BRCA1 residues are marked relative to the translation initiation site.
ing pattern identical to that of MS13 and MS110.(B) Synthesis of GST±BRCA1 fusion proteins in E. coli. Individual
However, as predicted, SG11 staining was blocked byGST±BRCA1 fusion proteins were prepared as described in Experi-
mental Procedures. The figure depicts a Coomassie blue±stained preincubation with a C-terminal BRCA1 polypeptide
SDS acrylamide gel, showing the relative abundance of each fusion containing the SG11 epitope (data not shown). There-
protein used in Figure 4C. Note that GST±BRCA1 protein #3 was fore, the immunostaining obtained with these MAb's
consistently found to be unstable.
likely reflects specific interactions of these MAb's with(C) Rad51 antiserum recognizes a 38 kDa protein bound to GST±
BRCA1.BRCA1 #4. GST±BRCA1 affinity beads were incubated briefly with
A further indication of the specifity of the BRCA1stain-an unlabeled BJAB extract. After washing, bound proteins were
electrophoresed and immunoblotted using the Rad51 antiserum as ing pattern is given by the failure of monoclonal antibod-
probe. The figure shows a 38 kDa band, comigrating with Rad51 ies specific to other nuclear proteins, such as the retino-
detected in whole cell extracts (WCE), specifically associated with blastoma protein and the nuclear coactivator, p300, to
GST±BRCA1 #4. elicit any signal on human synaptonemal complexes.(D) The 38 kDa protein bound to GST±BRCA1 #4 is a product of the
Furthermore, testis spreads, prepared in this manner,human cell extract and can be reimmunoprecipitated with Rad51
stained positively for DNA (with DAPI) throughout theantiserum. Beads containing GST±BRCA1 #4 and excess GST-con-
taining affinity beads were incubated, in parallel, with extracts of nucleus. In S phase spermatocytes, nuclei also stained
35S-methionine-labeled MCF7. After washing, bound proteins were with Ab to the replication protein, RPA, throughout, indi-
solubilized by boiling in SDS buffer. Diluted eluates were then immu- cating that the method of preparation does not extract
noprecipitated with Rad51 antiserum, and the ensuing precipitates
non-SC-bound proteins from the spreads (A. Plug andwere analyzed by SDS±PAGE and autoradiography. The specific 38
T. Ashley, unpublished data). The unsynapsed/axial ele-kDa band (indicated with an arrow) was found in another experiment
ments, therefore, appear to be the only sites of BRCA1to comigrate with the 38 kDa Rad51 protein, as identified by immu-
noblotting. Furthermore, an anti-Rad51 reimmunoprecipitate from concentration in zygotene and pachytene spermato-
an initial anti-Rad51 precipitate of MCF7 cells yielded only a 35S- cytes.
labeled 38 kDa species (not shown).
Simultaneous BRCA1 and Rad51 Staining
of Meiotic Chromosomesexistence of BRCA1 staining on unsynapsed axial ele-
ments (small arrows). Arrowheads mark examples of Plug et al. (1996) showed that Rad51 is present in pre-
meiotic S phase nuclear foci. During zygonema, Rad51synapsed regions of the indicated synaptonemal com-
plexes. Identical results were obtained with all three staining organizes into discrete structures along axial
elements. Homologous synapsis is completed in earlyBRCA1 Ab's, strongly suggesting that the observed sig-
nals resulted from the presence of BRCA1. pachynema, and Rad51 foci remain evident along the
Cell
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Figure 5. Localization of BRCA1 Staining to Meiotic Chromosomes
(A) Axial and synapsed segments (using Ab SCP3, white) in a human zygotene nucleus. BRCA1 (stained with MAb MS110, red) localized to
discrete sites along unsynapsed axial elements (examples noted by small arrows) and axes that are in the process of synapsing (examples
noted by larger arrows).
(B) Localization of BRCA1 to sites along unsynapsed axes of regions delayed in synapsis (examples noted by arrowheads), pairing forks
(example noted by arrow), and remaining univalents (examples noted by small arrows).
(C) Pachytene nucleus showing the presence of BRCA1 staining on the unsynapsed X chromosome and a delayed pairing fork (arrows).
(D) BRCA1 staining on unsynapsed axial elements (enlarged images taken, in part, from [B]). Arrows indicate examples of unsynapsed
segments; arrowheads indicate examples of synapsed regions. SCP3 staining (white) is shown on the left; SCP3 and BRCA 1 costaining (white
and red, respectively) are shown on the right. The lowermost complexes of the three are from another zygotene spread, where BRCA1 staining
was obtained with MS13.
length of the synaptonemal complex. Shortly after com- In multiple spreads, some foci of Rad51 staining were
not associated with a BRCA1 signal at all (Figure 7 andpletion of synapsis of most chromosomes, Rad51 foci
begin to disappear from the synaptonemal complex. In data not shown). One interpretation of the Rad51 and
BRCA1 staining patterns, described above, is that acontrast, Rad51 foci remain associated with the unsyn-
apsed axial element of the X chromosome in spermato- significant fraction of both the BRCA1 and the Rad51
staining, i.e., that which appears in the same generalcytes (Ashley et al., 1995; Plug et al., 1996). Rad51 foci
also remain associated with a few autosomal axes in chromosomal locations, is concentrated at unsynapsed
chromosomal sites.which synapsis isdelayed (Pluget al., unpublished data).
In coimmunostaining experiments, much of the BRCA1
staining (red, Figure 7B) and much, albeit not all, of Discussion
the Rad51 staining (green, Figure 7A; composite image,
Figure 7C) appeared in the same general locations on The data presented here show, for the first time, that
BRCA1 associates with Rad51, a human homolog ofdeveloping synaptonemal complexes during zygonema.
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Figure 6. Specificity of BRCA1 Staining of
Synaptonemal Complexes
(A) SCP3 staining of pachytene chromo-
somes.
(B) BRCA1 costaining of this spread with MAb
MS13 that had been preincubated with a
C-terminal GST±BRCA1 fusion protein, which
lacks the MS13 epitope. BRCA1 staining is
limited to the unsynapsed axes of the X chro-
mosome.
(C) SCP3 staining of pachytene chromo-
somes. A prominent X-chromosomal axis is
present.
(D) The same spread costained with MS13
preincubated with an N-terminal GST±BRCA1
fusion protein that contains the MS13
epitope.
bacterial RecA. In mitotic cells, this association was was present on synapsed regions. Atr is a homolog
of Mec-1 (S. cerevisiae), Rad3 (S. pombe), and mei-marked by colocalization in S phase nuclear foci and
41 (Drosophila), and mutations affecting these proteinscoimmunoprecipitation. Furthermore, during meiotic
lead to defects in DNA damage±induced cell cycle re-prophase in primary human spermatocytes, the proteins
sponses, radiation hypersensitivity, and defective meio-occupied the same general regions of developing syn-
sis (Al-Khodairy and Carr, 1992; Jiminez et al., 1992;aptonemal complexes. These findings suggest a func-
Rowley et al., 1992; Cimprich et al., 1996). These largetional relationship between thesetwo proteins. This con-
proteins are protein kinases, and, where studied, kinaseclusion was strengthened by the mapping of a Rad51
function was essential to their normal biological activityinteraction domain to BRCA1 residues 758±1064, the
(Bentley et al., 1996). This, in turn, suggests a role forsite of at least one naturally occurring, loss-of-function
these proteins in one or more signal transduction cas-missense mutation (Shattuck-Eidens et al., 1995).
cades, one product of which is proper meiotic and mi-Like Rad51, BRCA1 was detected in the nuclei of
totic checkpoint control (reviewed in Carr, 1996).human spermatocytes on the axial (unsynapsed) ele-
The question of whether BRCA1 and Atr interact isments of developing synaptonemal complexes. This is
now clearly relevant. Their similar locations on meioticconsistent with the prior observation that BRCA1 mRNA
chromosomes, the known contribution of Atr to DNAlevels are greatly elevated in zygotene/pachytene
damage control, and its possible role in meiotic cellspermatocytes (Zabludoff et al., 1996). Since recombi-
cycle regulation (Keegan et al., 1996) suggest a relatednation, per se, occurs in synapsed regions, one might
role for BRCA1. The Atr equivalent function in mitoticspeculate that BRCA1 does not act directly in meiotic
cells could be monitoring intersister chromatid interac-crossing-over. If that were true, it is possible that BRCA1
tions during S and G2 (Kleckner, 1996). One wonders,
acts prior to the initiation of recombination, e.g., as an
then, whether Atr and, possibly, BRCA1 participate in
upstream regulator of this process. Alternatively, since
monitoring the progress of DNA replication and/or nor-
its association with meiotic structures developed and mal recombination-linked functions.
ended synchronously, one could argue that it functions Tumorigenesis can arise from defects in DNA repair,
only when it is detected on the meiotic chromosome, e.g., in the case of hereditary nonpolyposis colon can-
e.g., during a period when the search for homologous cer. There, the defects lie in certain mismatch repair
sequences initiates and proceeds and/or when double- genes (reviewed in Kolodner, 1996). The products of
strand breaks appear (reviewed in Kleckner, 1996). The some of these genes are also present on synaptonemal
relatively synchronous manner in which BRCA1 ap- complexes and participate in normal meiosis (Baker et
peared on meiotic chromosomes and formed dot struc- al., 1995; Baker et al., 1996; Edelmann et al., 1996). That
tures in mitotic cells suggests a role in both mitotic and BRCA1 and the product(s) of a second class of tumor
meiotic cell cycle control. suppressor genes that play a role in maintaining genome
Recently, the ATR and ATM gene products were de- integrity are intimately associated with synaptonemal
tected on mutually exclusive regions of the synaptone- complexes raises the question of whether they commu-
mal complex (Keegan et al., 1996). Like BRCA1, Atr was nicate with one another.
found on axial elements, together with Rad51. Atm, the What might be the outcome of a specific BRCA1 inter-
product of another gene whose germ line inactivation action with Rad51? In yeast, Rad51 participates in dou-
ble-stranded break repair and meiotic recombinationmay predispose to breast cancer (Swift et al., 1987),
Cell
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Verma, 1996; Monteiro et al., 1996), one wonders
whether BRCA1 plays a role in mediating a response to
mammalian DNA damage in a Rad51/transcription±
dependent manner. Notable in this regard is the finding
of Reinberg and his coworkers of hRad51 in a fraction
of RNA polymerase II holoenzyme (Maldonado et al.,
1996).
Importantly, Rad51 and p53, another tumor suppres-
sor with a central role in the response to DNA damage,
interact, specifically, in vivo (Sturzbecher et al., 1996).
There is a putative p53 interaction sequence in BRCA1
(Koonin et al., 1996) that is distinct from the apparent
Rad51 interacting region of BRCA1. p53 also serves as
an hereditary breast cancer±inducing gene in patients
with the Li-Fraumeni Syndrome (Malkin et al., 1990).
On the face of it, the phenotype (i.e., cell cycle arrest)
of BRCA1 knockout embryos would seem to run counter
toa proposed tumor suppressingrole for this protein. On
the otherhand, if BRCA1has a role in the maintenance of
genome integrity, loss of its function might result in
genome errors and the subsequent activation of check-
point genome guardian functions, the outcome of which
might be cell cycle arrest. Perhaps only those cells that
are already defective in monitoring genome integrity
and/or responding to a defect therein can escape the
proliferation defect of BRCA1 loss. If this is the case,
then loss of BRCA1 function, per se, may not initiate
tumorigenesis, but rather accelerate its progression in
cells that have already sustained damage to such a
checkpoint function.
Interestingly, only trophoblast cells of BRCA1 knock-
out embryos developed normally (Hakem et al., 1996).
This tissue is unusual in that it normally undergoes en-
doreplication. If BRCA1 loss trips a normal S phase
checkpoint, these cells may not be susceptible to it.
Rad51 loss is lethal in mice but not in yeast, a unicellu-
lar organism that may not be subjected to all of the
same checkpoint and cell cycle controls as multicellular
organisms. Interestingly, yeast also lack a BRCA1 gene.
Figure 7. Colocalization of BRCA1 and Rad51 on Meiotic Chromo-
somes Experimental Procedures
(A) Rad51 immunostaining (green).
(B) BRCA1 immunostaining (red, MS13). Tissue Culture Methods and Preparation of Cell Extracts
(C) Rad51 and BRCA1 costaining (colocalization is reflected by yel- Cells were cultured in DMEM-10% fetal bovine serum (FBS), or 10%
low images). Fetal Clone I (Hyclone labs). For synchronization studies of MCF7
cells, asynchronous cultures were cultivated for 24 hr in DMEM/
0.05% BSA to induce G1 arrest. After release into 20% FBS, cell(Shinohara et al., 1992). Indeed, it must also play some
cycle progression was measured by FACS analysis. Maximum S
role in the normal replication of mammalian embryonic phase enrichment was seen 24 hr after serum release. For transfec-
cells, since Rad512/2 murine zygotes undergo early repli- tion, a standard calcium phosphate precipitation method was used
cation arrest (Lim and Hasty, 1996; Tsuzuki et al., 1996). (Wigler et al., 1977). Immunoprecipitation (typically z2 mg Ab per
reaction) and immunoblotting were performed as described pre-Finally, RecA function is essential for the SOS response,
viously (Scully et al., 1996), with the exception of the extractiona bacterial DNA damage control pathway dependent
buffer, which contained only NP-40 (0.5%) as detergent.upon the activated transcription of certain genes (re-
viewed in Echols and Goodman, 1991). Immunostaining of Adherent Cells
Given these facts, one outcome of the Rad51±BRCA1 Cells were fixed and permeablized as described previously (Eckner
interaction could be orderly cell cycle progression, high et al., 1994). Primary antibodies were incubated in a humidified
fidelity DNA replication, and/or events that lead to the atmosphere at 378C for 20 min. Species-specific, fluorochrome-
conjugated secondary antibodies (Jackson Immunoresearch) weremaintenance of genomic integrity. Indeed, BRCA1
incubated in a similar fashion. Immunofluorescence was recordedbreast tumors are characterized by a greater degree of
using a Zeiss confocal microscope.genome plasticity than those arising in patients with
mutations in theBRCA2 gene (Marcus et al., 1996). Simi- Preparation and Immunostaining of Human
larly, given the essential role of RecA in the SOS re- Synaptonemal Complexes
sponse and the apparent transcription activation func- Preparation of ªspreadsº of human spermatocytes was perfomed as
described by Peters et al. (1997). Antibody incubation and detectiontion of certain BRCA1 fusion proteins (Chapman and
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were performed as described previously (Moens et al., 1987; Ashley helpful discussions. We are grateful to Drs. Adam Kibel and Jerome
Ritchie for their expert help inobtaining testis tissue for these experi-et al., 1995). BRCA1 MAb's were detected with anti-mouse IgG
rhodamine conjugate (Pierce), and SCP3 polyclonal antibodies with ments. Drs. Charles Radding, Efim Golub, Gurucharan Reddy, and
Oleg Kovalenko generously provided affinity-purified hRad51 anti-anti-rabbit IgG FITC conjugate (Pierce). Preparations were counter-
stained with 49,69 diamino-2-phenylindole (DAPI, Sigma), mounted body, and we thank them enthusiastically for it. We also thank Dr.
Christa Heyting for her generosity in supplying SCP3 antibody andin a DABCO (Sigma) antifade solution, and examined on a Zeiss
Axioskop (63-X and 100-X, 1.2 Plan Neofluor oil immersion objec- Mr. Phillipe Male for processing meiosis photographs. This work
was supported by grants from the National Institutes of Health andtive). Each fluorochrome image was captured separately as an 8-bit
source image using a computer-assisted cooled CCD camera (Pho- the Dana-Farber Women's Cancer Program.
tometrics CH 220). The separate images were 24-bit pseudocolored
and merged with custom software developed by Tim Rand (Ried et Received December 2, 1996; revised December 20, 1996.
al., 1992).
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